Description/Abstract

The COVID-19 pandemic has caused rising anxiety and a corresponding increase in benzodiazepine prescriptions. Experts worry that inconsistent access to physicians as a result of stay-at-home orders will lead dependent patients to seek counterfeit or street drugs if their prescriptions lapse. This brief discusses these repercussions and recommends approaches to monitor and support those suffering from anxiety.

Document Type

Issue Brief

Keywords

anxiety, COVID19, coronavirus, anti-anxiety drugs, prescription drugs, mental health

Disciplines

Psychiatric and Mental Health | Substance Abuse and Addiction

Date

1-26-2021

Acknowledgements

The authors would like to thank Megan Ray and Shannon Monnat for edits on previous drafts.

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS